A Clinical Control Study of Mengshi Ditan Decoction Combined with Western Medicine for Schizophrenia

HU Hai-yan1; ZHU Wei-ming2; ZHENG Hong3

doi:10.13288/j.11-2166/r.2007.02.015

您当前的位置：

首页 >

文章列表页 >

A Clinical Control Study of Mengshi Ditan Decoction Combined with Western Medicine for Schizophrenia

更新时间：2021-11-17

- A Clinical Control Study of Mengshi Ditan Decoction Combined with Western Medicine for Schizophrenia
- Journal of Traditional Chinese Medicine Issue 2, Pages: 129-131(2007)
- 作者机构：
  
  1. 温州医学院第二临床学院中医基础教研室
  2. 温州市鹿城精神病医院
  3. 温州医学院附属第二医院浙江省温州市学院西路82号
  4. ,325003
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2007.02.015
  CLC： R749.3
- Published：2007
- 稿件说明：
移动端阅览
[1]胡海燕,朱未名,郑虹.礞石涤痰汤结合西药治疗精神分裂症临床对照研究[J].中医杂志,2007(02):129-131.

HU Hai-yan1, ZHU Wei-ming2, ZHENG Hong3. A Clinical Control Study of Mengshi Ditan Decoction Combined with Western Medicine for Schizophrenia[J]. Journal of Traditional Chinese Medicine2007, (2): 129-131.
[1]胡海燕,朱未名,郑虹.礞石涤痰汤结合西药治疗精神分裂症临床对照研究[J].中医杂志,2007(02):129-131. DOI： 10.13288/j.11-2166/r.2007.02.015.

HU Hai-yan1, ZHU Wei-ming2, ZHENG Hong3. A Clinical Control Study of Mengshi Ditan Decoction Combined with Western Medicine for Schizophrenia[J]. Journal of Traditional Chinese Medicine2007, (2): 129-131. DOI： 10.13288/j.11-2166/r.2007.02.015.

摘要

目的探讨礞石涤痰汤治疗精神分裂症的临床疗效。方法96例精神分裂症患者随机分为两组

对照组用抗精神分裂症西药治疗

治疗组在西药治疗的基础上加服礞石涤痰汤

治疗6周评定疗效。用阳性与阴性症状表（PANSS）、简明精神病量表（BPRS）因子评分和副反应量表（TESS）评定疗效和不良反应。结果治疗组显效率为64.00%

对照组为43.48%（P<0.01）

治疗组不良反应少于对照组（P<0.05或P<0.01）。结论中药礞石涤痰汤对精神分裂症有治疗作用。中西医结合治疗精神分裂症疗效优于单纯西药治疗

其毒副反应轻于单纯西药治疗。

Abstract

Objective To study the therapeutic effect of Mengshi Ditan Decoction （Mica Phlegm-Flushing Decoction） for schizophrenia.Methods Totally 96 cases of schizophrenia were randomly divided into 2 groups.The control group was treated by western medicine

while Mengshi Ditan Decoction was added in the treatment group.Positive and Negative Symptoms Scale （PANSS）

Brief Psychiatric Rating Scale （BPRS） and Treatment Emergent Symptom Scale （TESS） were used to identify the therapeutic and adverse effect after 6 weeks’ treatment.Results The excellence rate in treatment group was 64.00%

while 43.48% in control group （P<0.01）.The adverse effect in treatment group was less than that in control group （P<0.05 or P<0.01）.Conclusion Mengshi Ditan Decoction has therapeutic effect for schizophrenia.The therapeutic effect of integrated Chinese and western medicine treatment is superior to western medicine with less adverse effect and shorter treatment course.

关键词

Keywords

references

查看原文

Views

198

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

JIA Hongxiao's Clinical Experience in Treating Cognitive Impairments in Schizophrenia based on Five Spirits Stored in Corresponding Viscera Theory

Experiences of ZHAO Yonghou in Differentiation and Staged Treatment of Schizophrenia Using the Theory of Ti （Character，体） and Yong （Function，用） in Mental Illness

Effects of Yudian Decoction （愈癫汤） on the Metabolic Balance of Glu/GABA in the Brain Tissue of Schizophrenia Model Rats

Effects of Ginkgo Leaf Capsules （银杏叶胶囊） Combined with Aripiprazole on Cognitive Function of Patients with Schizophrenia

Acupuncture Treatment for Refractory Auditory Hallucination in Schizophrenia Patients——A Report of 50 Cases

Related Author

贾竑晓

WANG Dan

FENG Sitong

YIN Xia

NING Yanzhe

CHAI Jianbo

ZHAO Sihan

CHANG Haojie

Related Institution

Mental Health Center， Inner Mongolia Autonomous Region

Changping District Hospital of Integrated Traditional Chinese and Western Medicine

Advanced Innovation Center for Human Brain Protection， Capital Medical University

Beijing Anding Hospital， Capital Medical University/National Clinical Research Center for Mental Disorders

Graduate School， Heilongjiang University of Chinese Medicine

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰